Investment Rating - The report assigns a "Buy" rating to the company with a current price of 8.70 CNY and a fair value of 10.50 CNY [2]. Core Insights - The company, Qingsong Co., Ltd., has transitioned to focus on the cosmetics ODM sector, with a significant recovery in profitability expected as operational efficiencies improve and customer orders rebound [10]. - The company has undergone a strategic shift by divesting its turpentine business and acquiring 100% of the cosmetics OEM leader, Norsbel, enhancing its competitive position in the cosmetics manufacturing industry [15][16]. - The report forecasts a positive trend in revenue and net profit, with expected net profits of 1.3 billion CNY in 2025, 1.8 billion CNY in 2026, and 2.3 billion CNY in 2027, supported by a robust customer base and product focus [10]. Summary by Sections Company Overview - Qingsong Co., Ltd. has evolved from a turpentine producer to a leading player in the cosmetics ODM market, acquiring Norsbel to strengthen its business model [15]. - The company has faced challenges due to the pandemic and regulatory pressures but is now on a recovery path with improved operational efficiency [16]. Financial Analysis - The company reported revenues of 19.69 billion CNY in 2023, with a projected slight decline to 19.40 billion CNY in 2024, followed by a recovery to 21.11 billion CNY in 2025 [9][27]. - The net profit is expected to turn positive in 2024, with significant growth projected in subsequent years, reflecting a recovery from previous losses [10][27]. Industry Analysis - The global beauty and personal care market is projected to grow to 651.6 billion USD by 2024, with a steady recovery anticipated in the cosmetics sector [43]. - The Chinese cosmetics market is expected to reach 73.7 billion USD by 2025, indicating a shift towards stable growth as the industry matures [46]. - Regulatory changes are expected to benefit compliant companies, leading to increased market concentration and the exit of non-compliant players [51]. Strategic Focus - The company is concentrating on high-value product categories, particularly facial masks, and aims to enhance its customer base by focusing on key clients [10]. - The operational strategy includes optimizing product offerings and improving supply chain efficiency, which is expected to enhance profitability and market share [10].

Core Viewpoint - The company, Qing Song Co., Ltd., is primarily engaged in the design, research and development, and manufacturing of cosmetics, including facial masks, skincare products, and wet wipes, with a significant focus on ODM (Original Design Manufacturer) services [6][8]. Company Overview - The company operates in the chemical raw materials and chemical products manufacturing industry, specifically in the cosmetics manufacturing sector [6]. - The main business entity is its wholly-owned subsidiary, Nuo Si Bei Cosmetics Co., Ltd., which contributes 99.52% of the consolidated revenue [8]. Business Operations - Nuo Si Bei specializes in the design, research and development, and manufacturing of facial masks, skincare products, wet wipes, and non-woven fabric products, making it one of the largest domestic ODM companies in China [8]. - The upstream supply chain includes natural cellulose fibers, polyester fibers, and viscose fibers for mask substrates, while the downstream market consists of cosmetic brand owners and various retail channels, including e-commerce and physical stores [9]. Financial Data - The company has not restated or adjusted previous years' financial data, indicating stability in its financial reporting [10]. - The company has implemented a share repurchase plan, with a total repurchase amount of approximately RMB 65.8 million, representing 3.49% of the total share capital [11]. Major Projects - The company has decided to terminate the construction of a large industrial park project on 148 acres and is negotiating with government authorities to return the land use rights [12][13]. - A new investment partnership has been formed with Mi Jia Technology Co., Ltd. to develop the 148-acre land project, with Nuo Si Bei holding a 20% stake in the newly established joint venture [13][14]. Strategic Investments - The company has increased its stake in Guangdong Ke Pu Rui Biotechnology Co., Ltd. to 60%, enhancing its capabilities in synthetic biology and new material technology [15]. - A new wholly-owned subsidiary, Guangdong Nuo Mi Jia Biomedical Co., Ltd., has been established to support the company's strategic development needs [16].